These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 8617971

  • 1. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit.
    Shimizu Y, Ashman LK, Du Z, Schwartz LB.
    J Immunol; 1996 May 01; 156(9):3443-9. PubMed ID: 8617971
    [Abstract] [Full Text] [Related]

  • 2. Baseline and stimulated turnover of cell surface c-Kit expression in different types of human mast cells.
    Babina M, Rex C, Guhl S, Thienemann F, Artuc M, Henz BM, Zuberbier T.
    Exp Dermatol; 2006 Jul 01; 15(7):530-7. PubMed ID: 16761962
    [Abstract] [Full Text] [Related]

  • 3. Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells.
    Baghestanian M, Agis H, Bevec D, Bankl HC, Hofbauer R, Kress HG, Butterfield JH, Müller MR, Ashman LK, Füreder W, Willheim M, Lechner K, Valent P.
    Exp Hematol; 1996 Oct 01; 24(12):1377-86. PubMed ID: 8913283
    [Abstract] [Full Text] [Related]

  • 4. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.
    Sillaber C, Strobl H, Bevec D, Ashman LK, Butterfield JH, Lechner K, Maurer D, Bettelheim P, Valent P.
    J Immunol; 1991 Dec 15; 147(12):4224-8. PubMed ID: 1721642
    [Abstract] [Full Text] [Related]

  • 5. Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin.
    Ricotti E, Bertorello N, Vai S, Pagani A, Cordero Di Montezemolo L, Madon E, Basso G.
    Haematologica; 1999 Oct 15; 84(10):879-86. PubMed ID: 10509034
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation.
    Mekori YA, Metcalfe DD.
    J Immunol; 1994 Sep 01; 153(5):2194-203. PubMed ID: 7519644
    [Abstract] [Full Text] [Related]

  • 7. Role of stem cell factor and c-kit signaling in regulation of fetal intestinal epithelial cell adhesion to fibronectin.
    Shimizu M, Minakuchi K, Tsuda A, Hiroi T, Tanaka N, Koga J, Kiyono H.
    Exp Cell Res; 2001 Jun 10; 266(2):311-22. PubMed ID: 11399059
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing.
    Huttunen M, Naukkarinen A, Horsmanheimo M, Harvima IT.
    Arch Dermatol Res; 2002 Oct 10; 294(7):324-30. PubMed ID: 12373338
    [Abstract] [Full Text] [Related]

  • 12. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
    Ceponis A, Konttinen YT, Takagi M, Xu JW, Sorsa T, Matucci-Cerinic M, Santavirta S, Bankl HC, Valent P.
    J Rheumatol; 1998 Dec 10; 25(12):2304-14. PubMed ID: 9858422
    [Abstract] [Full Text] [Related]

  • 13. Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor.
    Gattei V, Aldinucci D, Quinn JM, Degan M, Cozzi M, Perin V, Iuliis AD, Juzbasic S, Improta S, Athanasou NA, Ashman LK, Pinto A.
    Cell Growth Differ; 1996 Jun 10; 7(6):753-63. PubMed ID: 8780889
    [Abstract] [Full Text] [Related]

  • 14. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
    Wang CH, Verma S, Hsieh IC, Hung A, Cheng TT, Wang SY, Liu YC, Stanford WL, Weisel RD, Li RK, Cherng WJ.
    Arterioscler Thromb Vasc Biol; 2007 Mar 10; 27(3):540-7. PubMed ID: 17204664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor.
    Lantz CS, Huff TF.
    J Immunol; 1995 Oct 15; 155(8):4024-9. PubMed ID: 7561112
    [Abstract] [Full Text] [Related]

  • 17. Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues.
    Hirota S, Nomura S, Asada H, Ito A, Morii E, Kitamura Y.
    Arch Pathol Lab Med; 1993 Oct 15; 117(10):996-9. PubMed ID: 7692836
    [Abstract] [Full Text] [Related]

  • 18. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.
    Reber L, Da Silva CA, Frossard N.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):327-40. PubMed ID: 16483568
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.
    Jahanyar J, Youker KA, Torre-Amione G, Koerner MM, Bruckner B, Noon GP, Loebe M.
    J Heart Lung Transplant; 2008 Jul 08; 27(7):701-9. PubMed ID: 18582797
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors.
    Oskeritzian CA, Wang Z, Kochan JP, Grimes M, Du Z, Chang HW, Grant S, Schwartz LB.
    J Immunol; 1999 Nov 01; 163(9):5105-15. PubMed ID: 10528217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.